Department of Ophthalmology, University Eye Hospital, Hannover Medical School, Carl-Neuberg-Str.1, 30625, Hannover, Germany.
Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str.1, 30625, Hannover, Germany.
BMC Ophthalmol. 2019 Aug 28;19(1):195. doi: 10.1186/s12886-019-1202-2.
The subconjunctival anesthesia with local anesthetics is considered as a low-risk procedure allowing ocular surgery without serious complications typical for retro- or parabulbar anesthesia, especially in patients with preexisting Optic Nerve damage. We report development of ipsilateral transient amaurosis accompanied with mydriasis and both, direct and consensual light response absence.
Three patients with advanced refractory glaucoma undergoing laser cyclophotocoagulation (CPC) for intraocular pressure lowering experienced these adverse effects just few minutes after subconjunctival injection of mepivacaine 2% solution (Scandicaine® 2%, without vasoconstrictor supplementation). The vision was completely recovered to usual values in up to 20 h after mepivacaine application. Extensive ophthalmological examination, including cranial magnetic resonance imaging (MRI), revealed no further ocular abnormalities, especially no vascular constriction or thrombotic signs as well as no retinal detachment. The oculomotor function remained intact. The blockade of ipsilateral ciliary ganglion parasympathetic fibers by mepivacaine may be the responsible mechanism. Systemic pathways as drug-drug interactions seem to be unlikely involved. Importantly, all three patients tolerated the same procedure previously or at a later date without any complication. Overall, our thoroughly elaborated risk management could not determine the causative factor explaining the observed ocular complications just in the current occasion and not at other time points.
Doctors should be aware and patients should be informed about such rare complications after subconjunctival local anesthetics administration. Adequate risk management should insure patients' safety.
局部麻醉下的球结膜下麻醉被认为是一种低风险的手术,可以在没有视神经损伤等严重并发症的情况下进行眼部手术,特别是在有视神经损伤的患者中。我们报告了一例同侧短暂性失明伴瞳孔散大,直接和间接光反应均消失。
三名晚期难治性青光眼患者接受激光睫状环光凝术(CPC)以降低眼内压,在球结膜下注射 2%甲哌卡因(Scandicaine® 2%,无血管收缩剂补充)后几分钟内出现这些不良反应。在甲哌卡因应用后长达 20 小时,视力完全恢复到正常水平。广泛的眼科检查,包括头颅磁共振成像(MRI),未发现进一步的眼部异常,特别是没有血管收缩或血栓形成迹象,也没有视网膜脱离。眼动神经功能保持完整。甲哌卡因可能阻断了同侧睫状神经节副交感纤维。全身途径(如药物相互作用)似乎不太可能参与其中。重要的是,所有三名患者之前或之后的同一手术都没有任何并发症。总体而言,我们详细制定的风险管理无法确定导致当前观察到的眼部并发症的原因,而不是其他时间点。
医生应注意并告知患者在球结膜下局部麻醉后可能出现这种罕见的并发症。充分的风险管理应确保患者的安全。